한국동물위생학회지 (Korean Journal of Veterinary Service)

  • 제40권4호
  • /
  • Pages.287-292
  • /
  • 2017
  • /
  • 3022-7372(pISSN)
  • /
  • 2287-7630(eISSN)
한국동물위생학회 (The Korean Society of Veterinary Service)
권호 표지
DOI QR코드

DOI QR Code

Prognosis evaluation of a great dane dog with dilated cardiomyopathy

  • Kim, Yun-Hye (BK21 Plus Team and College of Veterinary Medicine, Chonbuk National University) ;
  • Na, Jiung (BK21 Plus Team and College of Veterinary Medicine, Chonbuk National University) ;
  • So, Kyung-Min (Animal Nutrition and Physiology Team, National Institute of Animal Science, Rural Development Administration) ;
  • Park, Chul (BK21 Plus Team and College of Veterinary Medicine, Chonbuk National University)
  • 투고 : 2017.11.16
  • 심사 : 2017.12.23
  • 발행 : 2017.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A five-year-old, male, Great Dane weighing 107 kg was presented with anorexia, abdominal distension, and dyspnea for 5 days. Physical examination, blood works, radiography, electrocardiography (ECG), and echocardiography were performed. Based on severely low fractional shortening (FS) and marked four chamber enlargement in echocardiography, continuous atrial fibrillation and occasional ventricular premature complex (VPC) on ECG, the dog was diagnosed as dilated cardiomyopathy (DCM) concurrent with congestive heart failure. Pleural effusion and ascites were modified transudate. In accordance with DCM scoring system recommended by European Society of Veterinary Cardiology (ESVC), DCM score was 13/15 in this case. Concentrations of cTnI and NT-pro-BNP were 1.0 ng/mL and 693 pmol/L, respectively. Since the former and the latter were remarkably high values, it was certain that the patient had grave prognosis. Intensive care was performed for the dog and the clinical signs as well as the radiographic abnormalities were resolved. However, when he presented serious dyspnea again at 25 days post therapy, the dog was dead. In case of canine DCM, the scoring system for the diagnosis and cardiac biomarkers including NT-pro-BNP and cTnI could be useful to advise owners on the status and prognosis of their dog with DCM.

키워드

참고문헌

  1. Borgarelli M, Santilli RA, Chiavegato D, D'Agnolo G, Zanatta R, Mannelli A, Tarducci A. 2006. Prognostic indicators for dogs with dilated cardiomyopathy. J Vet Intern Med 20: 104-110. https://doi.org/10.1111/j.1939-1676.2006.tb02829.x
  2. Boswood A, Dukes-McEwan J, Loureiro J, James R, Martin M, Stafford-Johnson M, Smith P, Little C, Attree S. 2008. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 49: 26-32.
  3. Calvert CA, Pickus CW, Jacobs GJ, Brown J. 1997. Signalment, Survival, and Prognostic Factors in Doberman Pinschers With End-Stage Cardiomyopathy. J Vet Intern Med 11: 323-326. https://doi.org/10.1111/j.1939-1676.1997.tb00474.x
  4. Calvert CA, Wall M. 2001. Results of ambulatory electrocardiography in overtly healthy Doberman Pinschers with equivocal echocardiographic evidence of dilated cardiomyopathy. J Am Vet Med Assoc 219: 782-784. https://doi.org/10.2460/javma.2001.219.782
  5. Dukes-McEwan J, Borgarelli M, Tidholm A, Vollmar AC, Haggstrom J, The ESVC Taskforce for Canine Dilated Cardiomyopathy. 2003. Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J Vet Cardiol 5: 7-19.
  6. Fonfara S, Loureiro J, Swift S, James R, Cripps P, Dukes-McEwan J. 2010. Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs. Vet J 184: 334-339. https://doi.org/10.1016/j.tvjl.2009.04.004
  7. Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, MacDonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF. 2009. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J Vet Cardiol 11: S51-S61. https://doi.org/10.1016/j.jvc.2008.12.001
  8. Keene B, Panciera D, Atkins C, Regitz V, Schmidt M, Shug A. 1991. Myocardial L-carnitine deficiency in a family of dogs with dilated cardiomyopathy. J Am Vet Med Assoc 198: 647-650.
  9. Kittleson MD, Keene B, Pion PD, Loyer CG. 1997. Results of the Multicenter Spaniel Trial (MUST): Taurine-and Carnitine-Responsive Dilated Cardiomyopathy in American Cocker Spaniels With Decreased Plasma Taurine Concentration. J Vet Intern Med 11: 204-211. https://doi.org/10.1111/j.1939-1676.1997.tb00092.x
  10. Koch J, Pedersen H, Jensen AL, Flagstad A. 1996. M-mode Echocardiographic Diagnosis of Dilated Cardiomyopathy in Giant Breed Dogs. J Vet Intern Med Series A 43: 297-304. https://doi.org/10.1111/j.1439-0442.1996.tb00456.x
  11. Limas C, Goldenberg I, Limas C. 1989. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 64: 97. https://doi.org/10.1161/01.RES.64.1.97
  12. Martin M, Stafford Johnson M, Celona B. 2009. Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases. J Small Anim Pract 50: 23-29. https://doi.org/10.1111/j.1748-5827.2008.00659.x
  13. Martin M, Stafford Johnson M, Strehlau G, King J. 2010. Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases. J Small Anim Pract 51: 428-436. https://doi.org/10.1111/j.1748-5827.2010.00966.x
  14. Menaut P, Belanger MC, Beauchamp G, Ponzio NM, Moise NS. 2005. Atrial fibrillation in dogs with and without structural or functional cardiac disease: a retrospective study of 109 cases. J Vet Cardiol 7: 75-83. https://doi.org/10.1016/j.jvc.2005.07.002
  15. Meurs KM, Miller MW, Wright NA. 2001. Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis: 17 cases (1990-2000). J Am Vet Med Assoc 218: 729-732. https://doi.org/10.2460/javma.2001.218.729
  16. Monnet E, Orton EC, Salman M, Boon J. 1995. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators. J Vet Intern Med 9: 12-17. https://doi.org/10.1111/j.1939-1676.1995.tb03266.x
  17. Noszczyk-Nowak A. 2011. NT-pro-BNP and troponin I as predictors of mortality in dogs with heart failure. Pol J Vet Sci 14: 551-556.
  18. O'Sullivan ML, O'Grady MR, Minors SL. 2007. Plasma Big Endothelin-1, Atrial Natriuretic Peptide, Aldosterone, and Norepinephrine Concentrations in Normal Doberman Pinschers and Doberman Pinschers with Dilated Cardiomyopathy. J Vet Intern Med 21: 92-99. https://doi.org/10.1111/j.1939-1676.2007.tb02933.x
  19. Olson TM, Michels VV, Thibodeau SN, Tai Y-S, Keating MT. 1998. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750-752. https://doi.org/10.1126/science.280.5364.750
  20. Oyama MA, Boswood A, Connolly DJ, Ettinger SJ, Fox PR, Gordon SG,Rush JE, Sisson DD, Stepien RL, Wess G, Zannad F. 2013. Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease. J Am Vet Med Assoc 243: 71-82. https://doi.org/10.2460/javma.243.1.71
  21. Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M. 2008. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 232: 1496-1503. https://doi.org/10.2460/javma.232.10.1496
  22. Oyama MA, Sisson DD, Solter PF. 2007. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res 68: 42-47. https://doi.org/10.2460/ajvr.68.1.42
  23. Oyama MA, Sisson DD. 2004. Cardiac Troponin-I Concentration in Dogs with Cardiac Disease. J Vet Intern Med 18: 831-839 https://doi.org/10.1111/j.1939-1676.2004.tb02629.x
  24. Sandusky GE, Cho D. 1984. Congestive cardiomyopathy in a dog associated with pregnancy. Cornell Vet 74: 60-64.
  25. Schultheiss H, Bolte H. 1985. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 17: 603-617. https://doi.org/10.1016/S0022-2828(85)80029-8
  26. Sisson DD, Thomas WP, Keene BW. Primary myocardial disease in the dog. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine 5th edition Philadelphia. WB Saunders 2000: 874-895.
  27. Sleeper, MM, Clifford, CA, Laster, LL. 2001. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 15: 501-503 https://doi.org/10.1111/j.1939-1676.2001.tb01582.x
  28. Tarnow I, Olsen LH, Kvart C, Hoglund K, Moesgaard SG, Kamstrup TS,Pedersen HD, Haggstrom J. 2009. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J 180: 195-201. https://doi.org/10.1016/j.tvjl.2007.12.026
  29. Tidholm A, Haggstrom J, Borgarelli M, Tarducci A. 2001. Canine idiopathic dilated cardiomyopathy. Part I: aetiology, clinical characteristics, epidemiology and pathology. Vet J 162: 92-107. https://doi.org/10.1053/tvjl.2001.0571
  30. Tidholm A. 2006. Survival in dogs with dilated cardiomyopathy and congestive heart failure treated with digoxin, furosemide and propranolol: A retrospective study of 62 dogs. J Vet Cardiol 8: 41-47. https://doi.org/10.1016/j.jvc.2006.01.003
  31. Wess G, Butz V, Mahling M, Hartmann K. 2011. Evaluation of N-terminal pro-B-type natriuretic peptide as a diagnostic marker of various stages of cardiomyopathy in Doberman Pinschers. Am J Vet Res 72: 642-649. https://doi.org/10.2460/ajvr.72.5.642
  32. Wess G, Schulze A, Butz V, Simak J, Killich M, Keller L, Maeurer J, Hartmann K. 2010. Prevalence of dilated cardiomyopathy in Doberman Pinschers in various age groups. J Vet Intern Med 24: 533-538. https://doi.org/10.1111/j.1939-1676.2010.0479.x
  33. Wynne J, Braunwald E. The cardiomyopathies and myocardities. In: Heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia (Pa): WB Saunders. 2001: 1751-1806.